The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling

Dithiocarbamate has been tested for its effective anti-tumor activity, but the underlying mechanism remains unclear. We previously prepared a novel diththiocarbamate derivative, DpdtC with an ability of catalase inhibition. Here, we for the first time investigated the growth inhibition effects of Dp...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Rep
Main Authors: Yang, Yun, Liu, Youxun, Guo, Rui, Fu, Yun, Zhang, Ziheng, Zhang, Pengfei, Zhou, Pingxin, Wang, Tingting, Huang, Tengfei, Li, Xiaotong, Li, Changzheng
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2018
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821706/
https://ncbi.nlm.nih.gov/pubmed/29467385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-21768-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים